Deloitte Releases 12th Annual Life Sciences Industry Accounting Guide
Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
On Mar. 16 Deloitte released its 12th annual Life Sciences Industry Accounting Guide. The report provides a comprehensive look at some of the complex issues that finance and accounting professionals in the life sciences industry face including R&D costs, acquisitions and divestitures, consolidation, contingencies, revenue recognition, income taxes, financial instruments, and financial statement presentation and disclosure.
Some of the main themes from this year’s edition include:
- COVID-19-Related Accounting and Financial Reporting Considerations for Life Sciences Entities
- IPOs and SPACs
- Revenue Recognition
- Structured Trade Payable Arrangement
For additional information and the full report, click here.
Lilly Bolsters ALS Pipeline Through $415 Million Licensing Agreement with Alchemab Therapeutics
May 6th 2025Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly will assume responsibility for further development and commercialization of the novel platform.
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
April 22nd 2025With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics production, gene therapy capabilities, and next generation R&D centers.
